Comprehensive insight on the various healthcare team members a hematologist-oncologist may work with to optimize care of myeloproliferative neoplasms.
New Drug May Decrease Need for Blood Draws in Patients With PV
Treatment with rusfertide led to a decrease in the need for blood draws and decreased levels of red blood cells in patients with polycythemia vera.
Read More
FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.
Listen
Community Helped a Patient When Their MPN Treatment Was Delayed
Thomas Silver discusses how a community of support helped a patient when his bone marrow transplant was delayed.
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.
Patient-Nurse Relationships Are ‘Key to Proper Management of an MPN’
For patients with myeloproliferative neoplasms, it is essential to have an open relationship with oncology nurses, an expert explained.
Expert Hopes to See New Drug Combinations for MPNs in 2024
Dr. Lucia Masarova sat down with CURE® and discussed the advancements she hopes to see in 2024 for the treatment of patients with myeloproliferative neoplasms.